Review
doi: 10.1016/s0168-8278(03)00079-5.
Lamivudine resistant occult HBV: implications for public health?
Affiliations
- PMID: 12663248
- DOI: 10.1016/s0168-8278(03)00079-5
Item in Clipboard
Review
Lamivudine resistant occult HBV: implications for public health?
J Hepatol.
2003 Apr.
No abstract available
Comment in
-
Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection.J Hepatol. 2003 Apr;38(4):506-10. doi: 10.1016/s0168-8278(02)00457-9. J Hepatol. 2003. PMID: 12663244
Similar articles
-
Hepatitis B viral genotypes and lamivudine resistance.J Hepatol. 2002 Feb;36(2):303-4. doi: 10.1016/s0168-8278(01)00246-x. J Hepatol. 2002. PMID: 11830346 Clinical Trial. No abstract available.
-
Persistence of YMDD variants after withdrawal of Lamivudine.J Hepatol. 2002 Feb;36(2):304-5. doi: 10.1016/s0168-8278(01)00250-1. J Hepatol. 2002. PMID: 11830347 No abstract available.
-
[Lamivudine resistance impedes hepatitis B therapy].Fortschr Med. 1997 Apr 30;115(12):5. Fortschr Med. 1997. PMID: 9235306 German. No abstract available.
-
Hepatitis B virus resistance to antivirals: clinical implications and management.J Hepatol. 2003;39 Suppl 1:S133-8. doi: 10.1016/s0168-8278(03)00312-x. J Hepatol. 2003. PMID: 14708691 Review. No abstract available.
-
Adefovir-lamivudine combination therapy and hepatitis B viral kinetics.J Hepatol. 2005 Aug;43(2):200-2. doi: 10.1016/j.jhep.2005.05.011. J Hepatol. 2005. PMID: 15975684 Review. No abstract available.
Cited by
-
Occult HBV infection: a faceless enemy in liver cancer development.Viruses. 2014 Apr 8;6(4):1590-611. doi: 10.3390/v6041590. Viruses. 2014. PMID: 24717680 Free PMC article. Review.
-
Occult infection related hepatitis B surface antigen variants showing lowered secretion capacity.World J Gastroenterol. 2015 Feb 14;21(6):1794-803. doi: 10.3748/wjg.v21.i6.1794. World J Gastroenterol. 2015. PMID: 25684944 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
